Regina Ballinger and Deborah Komlos from Thomson Reuters are submitting an interesting editorial titled FDA Makes First Move on Biosimilars in the US, and they give us an insight into some Clinical Programs, Analytic Similarity in Biosimilars, Immunogenicity Assessments, and then they touch upon the The Future of Biosimilars in the US.
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte